These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31200495)

  • 21. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
    Nowell J; Blunt E; Gupta D; Edison P
    Ageing Res Rev; 2023 Aug; 89():101979. PubMed ID: 37328112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Plant-Derived Flavonoids and Their Mechanism in Attenuation of Alzheimer's and Parkinson's Diseases: An Update of Recent Data.
    Hussain G; Zhang L; Rasul A; Anwar H; Sohail MU; Razzaq A; Aziz N; Shabbir A; Ali M; Sun T
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29614843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases.
    Chen SQ; Wang ZS; Ma YX; Zhang W; Lu JL; Liang YR; Zheng XQ
    Molecules; 2018 Feb; 23(3):. PubMed ID: 29495349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
    Nakajima A; Ohizumi Y
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective Effects of Ginseng Phytochemicals: Recent Perspectives.
    Huang X; Li N; Pu Y; Zhang T; Wang B
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31416121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review.
    Bansal R; Singh R
    Med Res Rev; 2018 Jul; 38(4):1126-1158. PubMed ID: 28697282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids.
    Kooshki L; Zarneshan SN; Fakhri S; Moradi SZ; Echeverria J
    Phytomedicine; 2023 Apr; 112():154686. PubMed ID: 36804755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ghrelin as a neuroprotective and palliative agent in Alzheimer's and Parkinson's disease.
    Dos Santos VV; Rodrigues AL; De Lima TC; de Barioglio SR; Raisman-Vozari R; Prediger RD
    Curr Pharm Des; 2013; 19(38):6773-90. PubMed ID: 23530516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Drugs and Potential Future Neuroprotective Compounds for Parkinson's Disease.
    Carrera I; Cacabelos R
    Curr Neuropharmacol; 2019; 17(3):295-306. PubMed ID: 30479218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Bioactives in Neurodegenerative Diseases.
    Zacharia LC
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview on therapeutic and medicinal potential of poly-hydroxy flavone viz. Heptamethoxyflavone, Kaempferitrin, Vitexin and Amentoflavone for management of Alzheimer's and Parkinson's diseases: a critical analysis on mechanistic insight.
    Varshney M; Kumar B; Rana VS; Sethiya NK
    Crit Rev Food Sci Nutr; 2023; 63(16):2749-2772. PubMed ID: 34590507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms.
    Haddadi R; Shahidi Z; Eyvari-Brooshghalan S
    Phytomedicine; 2020 Dec; 79():153320. PubMed ID: 32920285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exendin-4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease.
    Verma A; Chaudhary S; Solanki K; Goyal A; Yadav HN
    Chem Biol Drug Des; 2024 Jan; 103(1):e14426. PubMed ID: 38230775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches.
    Cruz-Vicente P; Passarinha LA; Silvestre S; Gallardo E
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33920326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of natural products for the treatment of Alzheimer's disease.
    Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S
    Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases.
    Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J
    CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
    Rahul ; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unveiling Nature's potential: Promising natural compounds in Parkinson's disease management.
    Bhusal CK; Uti DE; Mukherjee D; Alqahtani T; Alqahtani S; Bhattacharya A; Akash S
    Parkinsonism Relat Disord; 2023 Oct; 115():105799. PubMed ID: 37633805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview.
    Libro R; Giacoppo S; Soundara Rajan T; Bramanti P; Mazzon E
    Molecules; 2016 Apr; 21(4):518. PubMed ID: 27110749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.